Ian Gowrie-Smith
Directeur/Membre du Conseil chez Theragnostics Ltd.
Profil
Ian Roderick Gowrie-Smith founded SkyePharma Plc in 1996, where he worked as Chairman from 1996 to 2006.
Mr. Gowrie-Smith also currently works at Theragnostics Ltd., as Director from 2015.
Mr. Gowrie-Smith also formerly worked at Tiberon Minerals Ltd., as Chairman, Tethyan Resource Corp., as Non-Executive Chairman, Rift Oil Ltd., as Chairman, Kea Petroleum Plc, as Non-Executive Chairman, and Medeva Plc, as Managing Director.
Postes actifs de Ian Gowrie-Smith
Sociétés | Poste | Début |
---|---|---|
Theragnostics Ltd.
Theragnostics Ltd. Medical SpecialtiesHealth Technology Part of Ariceum Therapeutics GmbH, Theragnostics Ltd. is a British company that develops and distributes diagnostic devices and therapeutics. The company is based in London, UK. The company was founded in 2013. Theragnostics was acquired by Ariceum Therapeutics GmbH on June 01, 2023 for $54.53 million. | Directeur/Membre du Conseil | 29/10/2015 |
Anciens postes connus de Ian Gowrie-Smith
Sociétés | Poste | Fin |
---|---|---|
TETHYAN RESOURCE CORP. | Président | 01/06/2010 |
Rift Oil Ltd.
Rift Oil Ltd. Contract DrillingIndustrial Services Part of Repsol SA, Rift Oil Ltd. is a British company that explores oil and gas. The company is based in London, UK. Rift Oil was founded in 2004. Rift Oil was acquired by Talisman Energy Holdings Ltd. on August 10, 2009 for $176.38 million. | Président | 10/08/2009 |
SKYEPHARMA PLC | Fondateur | 23/01/2006 |
KEA PETROLEUM PLC | Président | - |
Medeva Plc | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 7 |
---|---|
SkyePharma Plc
SkyePharma Plc Pharmaceuticals: OtherHealth Technology SkyePharma Plc engaged in the provision of pharmaceutical business. It involved in development and supply of pharmaceutical products. The company was founded by Ian Roderick Gowrie-Smith on August 18, 1910 and was headquartered in London, the United Kingdom. | Health Technology |
Tiberon Minerals Ltd.
Tiberon Minerals Ltd. Other Metals/MineralsNon-Energy Minerals Tiberon Minerals Ltd. used to engage in exploration and development of mineral properties. It produces tungsten, bismuth and copper. The company was founded by Loren Komperdo P. Geol in 1995 and headquartered in Toronto, Canada. | Non-Energy Minerals |
Tethyan Resource Corp.
Tethyan Resource Corp. Precious MetalsNon-Energy Minerals Tethyan Resource Corp. is a junior mineral exploration company, which focuses on gold and base metals. It engages in acquisition, exploration and evaluation of mineral properties in Serbia. It holds interest in the projects Rudnica copper-gold porphyry and Kizevak Zinc-lead-silver. The company was founded on June 2, 1999 and is headquartered in Vancouver, Canada. | Non-Energy Minerals |
Rift Oil Ltd.
Rift Oil Ltd. Contract DrillingIndustrial Services Part of Repsol SA, Rift Oil Ltd. is a British company that explores oil and gas. The company is based in London, UK. Rift Oil was founded in 2004. Rift Oil was acquired by Talisman Energy Holdings Ltd. on August 10, 2009 for $176.38 million. | Industrial Services |
Kea Petroleum Plc
Kea Petroleum Plc Oil & Gas ProductionEnergy Minerals Kea Petroleum PLC operates as a holding company, which engages in the oil and gas exploration activities. The company through its subsidiaries holds interests in three oil and gas exploration permits in the Taranaki, Northland basins and Mauku. Kea Petroleum was founded on September 18, 2009 and is headquartered in London, the United Kingdom. | Energy Minerals |
Medeva Plc | Health Technology |
Theragnostics Ltd.
Theragnostics Ltd. Medical SpecialtiesHealth Technology Part of Ariceum Therapeutics GmbH, Theragnostics Ltd. is a British company that develops and distributes diagnostic devices and therapeutics. The company is based in London, UK. The company was founded in 2013. Theragnostics was acquired by Ariceum Therapeutics GmbH on June 01, 2023 for $54.53 million. | Health Technology |